A Study to Evaluate the Safety and Pharmacokinetics of AD-118 and AD-1181 in Healthy Adult Subjects

Trial statusNot yet recruiting

Trial phasePhase 1

Trial typeInterventional

Biological sexAll

Age19-64

SponsorAddpharma Inc.

About this trial

A Study to Evaluate the Safety and Pharmacokinetics of AD-118 and AD-1181 Under Fasted Conditions in Healthy Adult Subjects

Body weight equal to or greater than 50kg and Body mass index (BMI) between 18.0 kg/m2 and 30.0 kg/m2 at the time of screening visit

Subjects aged 19 years or older and under 65 years at the screening visit

Participation in another clinical study with an investigational drug within the 6 months from scheduled first administration

Other exclusions applied

70 Participants

are divided into 2 treatment groups

Addpharma Inc.

Lead sponsor